Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/HLS stock hub

TSX/HLS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/HLSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
146.7M
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/HLS
In the news

Latest news · TSX/HLS

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-18.7
P25 -121.5P50 -40.9P75 0.5
ROIC-2.1
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/HLS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
198
Groups with data
11
Currency
USD
Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Canada
Country code
CA
Employees
85
Employees Change
-7%
Employees Change Percent
-7.61
Enterprise value
CAD 198.9M
Exchange
Toronto Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA40390B1094
Last refreshed
2026-05-10
Market cap
CAD 146.7M
Price
CAD 4.69
Price currency
CAD
Rev Per Employee
895,260.71x
Sector
Healthcare
Sic
2834
Symbol
tsx/HLS
Website
https://www.hlstherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-11.62%
EV Earnings
-11.67x
EV/EBITDA
8.19x
EV/FCF
8.57x
EV/Sales
2.61x
FCF yield
15.82%
P/B ratio
1.73x
P/S ratio
1.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
-7.4%
EBITDA Margin
30.98%
FCF margin
30.5%
Gross margin
71.55%
Gross Profit
CAD 54.4M
Gross Profit Growth
-5.36%
Gross Profit Growth Q
-3.53%
Gross Profit Growth3 Y
-7.86%
Gross Profit Growth5 Y
-3.32%
Net Income
CAD -17M
Net Income Growth Quarters
7%
Net Income Growth Years
2%
Pretax Margin
-23.2%
Profit Margin
-22.4%
Profit Per Employee
CAD -200,506
ROA
-1.73
Roa5y
-2.36
ROCE
-3.69
ROE
-18.69
Roe5y
-18.22
ROIC
-2.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr1y
4.46%
Cagr3y
-4.59%
Cagr5y
-23.52%
Div CAGR3
0%
EPS Growth Quarters
7
EPS Growth Years
2
FCF Growth
111.88%
FCF Growth Q
102.82%
FCF Growth3 Y
0.06%
FCF Growth5 Y
12.7%
OCF Growth
114.05%
OCF Growth Q
103.03%
OCF Growth3 Y
0.37%
OCF Growth5 Y
12.89%
Revenue Growth
-1.98x
Revenue Growth Q
-2.23x
Revenue Growth Years
0x
Revenue Growth3 Y
-3.35x
Revenue Growth5 Y
-0.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CAD 0.37
Assets
CAD 188.6M
Cash
CAD 16.1M
Current Assets
CAD 39.8M
Current Liabilities
CAD 35.7M
Debt
CAD 68.3M
Debt EBITDA
CAD 2.81
Debt Equity
CAD 0.81
Debt FCF
CAD 2.94
Equity
CAD 84.6M
Interest Coverage
-0.58
Liabilities
CAD 104M
Long Term Assets
CAD 148.8M
Long Term Liabilities
CAD 68.3M
Net Cash
CAD -52.2M
Net Cash By Market Cap
CAD -35.62
Net Debt EBITDA
CAD 2.22
Net Debt Equity
CAD 0.62
Net Debt FCF
CAD 2.25
Tangible Book Value
CAD -60.3M
Tangible Book Value Per Share
CAD -1.93
WACC
9.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.11
Inventory Turnover
1.84
Net Working Capital
CAD -5.4M
Quick ratio
0.75
Working Capital
CAD 4.1M
Working Capital Turnover
CAD 9.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
0.98%
Dividend per share
CAD 0
Last Dividend
CAD 0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
4.45%
200-day SMA
4.93
3Y total return
-13.15%
50-day SMA
4.49
50-day SMA vs 200-day SMA
50under200
5Y total return
-73.83%
All Time High
25.92
All Time High Change
-81.91%
All Time High Date
2019-12-31
All Time Low
3
All Time Low Change
56.33%
All Time Low Date
2024-08-26
ATR
0.1
Beta
0.83
Beta1y
0.6
Beta2y
0.91
Ch YTD
-2.7
High
4.7
High52
5.77
High52 Date
2025-10-01
High52ch
-18.65%
Low
4.69
Low52
4.22
Low52 Date
2026-03-12
Low52ch
11.14%
Ma50ch
4.43%
Price vs 200-day SMA
-4.89%
RSI
65.3
RSI Monthly
45.75
RSI Weekly
49.97
Sharpe ratio
0.13x
Sortino ratio
0.43
Total Return
0.98%
Tr YTD
-2.7
Tr1m
6.83%
Tr1w
0.86%
Tr3m
4.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -5.6M
Operating margin
-7.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
19,614,823%
Net Borrowing
-25,111,341.5
Shares Insiders
0.69%
Shares Institutions
1.17%
Shares Out
31,273,681
Shares Qo Q
6.28%
Shares Yo Y
-0.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
CAD 20.6M
Average Volume
7,389.15x
Bv Per Share
2.7
CAPEX
CAD -281,080
Ch1m
6.83
Ch1w
0.86
Ch1y
4.45
Ch3m
4.22
Ch3y
-13.15
Ch5y
-74.74
Ch6m
-11.84
Change
0%
Change From Open
-0.21
Close
4.69
Days Gap
0.21
Depreciation Amortization
29,116,798
Dollar Volume
66,129
Earnings Date
2026-05-15
EBIT
CAD -5.6M
EBITDA
CAD 23.6M
EPS
CAD -0.54
F Score
4
FCF
CAD 23.2M
FCF EV Yield
11.67x
FCF Per Share
CAD 0.74
Financing CF
-29,555,863
Fiscal Year End
December
Income Tax
CAD -610,148
Investing CF
-2,335,017
Is Primary Listing
1
Last Earnings Date
2026-03-12
Last Report Date
2025-12-31
Ma150
4.8
Ma150ch
-2.33%
Ma20
4.63
Ma20ch
1.21%
Net CF
-7,860,631
Next Earnings Date
2026-05-15
Open
4.7
P FCF Ratio
6.32
P OCF Ratio
6.24
Position In Range
0
Ppne
1,829,112.9
Price Date
2026-05-08
Price EBITDA
CAD 6.22
Relative Volume
1.85x
Revenue
76,097,160x
SBC By Revenue
3.45x
Share Based Comp
2,621,581
Tax By Revenue
-0.8x
Tr6m
-11.84%
Volume
14,100
Z Score
-0.89
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/HLS pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/HLS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+4.5%
S&P 500 1Y: n/a
3Y total return
-13.1%
S&P 500 3Y: n/a
5Y total return
-73.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TSX/HLS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.2%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.0%
Negative means the company is buying back shares.
Technical

TSX/HLS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
65.3
Neutral momentum band
Price vs 200-day MA
-4.9%
50/200-day relationship not available
Beta (5Y)
0.83
Moves roughly with the market
Sharpe ratio
0.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/HLS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/HLS stock rating?

tsx/HLS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/HLS analysis?

The full report lives at /stocks/tsx/HLS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/HLS?

The latest report frames tsx/HLS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/HLS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.